River Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.98M | Sell |
13,717
-1,155
| -8% | -$256K | 0.34% | 67 |
|
|
2025
Q4 | $3.4M | Sell |
14,872
-248
| -2% | -$56.5K | 0.38% | 60 |
|
|
2025
Q3 | $3.5M | Sell |
15,120
-143
| -0.9% | -$29.1K | 0.41% | 57 |
|
|
2025
Q2 | $2.83M | Sell |
15,263
-4
| -0% | -$743 | 0.35% | 65 |
|
|
2025
Q1 | $3.2M | Sell |
15,267
-769
| -5% | -$149K | 0.44% | 54 |
|
|
2024
Q4 | $2.85M | Sell |
16,036
-658
| -4% | -$121K | 0.38% | 62 |
|
|
2024
Q3 | $3.3M | Buy |
16,694
+221
| +1% | +$41.2K | 0.44% | 62 |
|
|
2024
Q2 | $2.83M | Buy |
16,473
+465
| +3% | +$77K | 0.41% | 65 |
|
|
2024
Q1 | $2.91M | Sell |
16,008
-718
| -4% | -$124K | 0.42% | 63 |
|
|
2023
Q4 | $2.59M | Sell |
16,726
-1,673
| -9% | -$244K | 0.41% | 67 |
|
|
2023
Q3 | $2.74M | Sell |
18,399
-1,348
| -7% | -$198K | 0.49% | 60 |
|
|
2023
Q2 | $2.66M | Sell |
19,747
-627
| -3% | -$91.9K | 0.45% | 63 |
|
|
2023
Q1 | $3.25M | Sell |
20,374
-1,056
| -5% | -$161K | 0.59% | 48 |
|
|
2022
Q4 | $3.46M | Sell |
21,430
-489
| -2% | -$75K | 0.67% | 44 |
|
|
2022
Q3 | $2.94M | Sell |
21,919
-2,679
| -11% | -$384K | 0.63% | 47 |
|
|
2022
Q2 | $3.77M | Buy |
24,598
+2,315
| +10% | +$354K | 0.69% | 40 |
|
|
2022
Q1 | $3.61M | Buy |
22,283
+560
| +3% | +$81.3K | 0.58% | 51 |
|
|
2021
Q4 | $2.94M | Buy |
21,723
+816
| +4% | +$96.4K | 0.46% | 64 |
|
|
2021
Q3 | $2.25M | Buy |
20,907
+244
| +1% | +$27.9K | 0.39% | 72 |
|
|
2021
Q2 | $2.33M | Buy |
20,663
+863
| +4% | +$97.2K | 0.41% | 67 |
|
|
2021
Q1 | $2.14M | Buy |
19,800
+1,837
| +10% | +$196K | 0.4% | 67 |
|
|
2020
Q4 | $1.93M | Buy |
17,963
+3,762
| +26% | +$362K | 0.42% | 66 |
|
|
2020
Q3 | $1.24M | Buy |
14,201
+567
| +4% | +$53.4K | 0.32% | 83 |
|
|
2020
Q2 | $1.34M | Buy |
13,634
+1,677
| +14% | +$148K | 0.41% | 74 |
|
|
2020
Q1 | $911K | Sell |
11,957
-1,231
| -9% | -$105K | 0.36% | 78 |
|
|
2019
Q4 | $1.17M | Buy |
13,188
+53
| +0.4% | +$4.4K | 0.39% | 75 |
|
|
2019
Q3 | $995K | Sell |
13,135
-182
| -1% | -$12.5K | 0.38% | 80 |
|
|
2019
Q2 | $968K | Sell |
13,317
-1,774
| -12% | -$139K | 0.38% | 77 |
|
|
2019
Q1 | $1.22M | Sell |
15,091
-563
| -4% | -$46.1K | 0.51% | 69 |
|
|
2018
Q4 | $1.44M | Sell |
15,654
-3,549
| -18% | -$312K | 0.64% | 53 |
|
|
2018
Q3 | $1.82M | Sell |
19,203
-921
| -5% | -$87.3K | 0.67% | 51 |
|
|
2018
Q2 | $1.86M | Buy |
20,124
+2,140
| +12% | +$209K | 0.73% | 46 |
|
|
2018
Q1 | $1.7M | Buy |
17,984
+773
| +4% | +$84.9K | 0.72% | 52 |
|
|
2017
Q4 | $1.66M | Buy |
17,211
+3,665
| +27% | +$345K | 0.69% | 56 |
|
|
2017
Q3 | $1.2M | Buy |
13,546
+3,215
| +31% | +$245K | 0.54% | 68 |
|
|
2017
Q2 | $749K | Hold |
10,331
| – | – | 0.35% | 94 |
|
|
2017
Q1 | $673K | Buy |
10,331
+625
| +6% | +$39.3K | 0.33% | 97 |
|
|
2016
Q4 | $608K | Hold |
9,706
| – | – | 0.31% | 96 |
|
|
2016
Q3 | $612K | Sell |
9,706
-235
| -2% | -$15.2K | 0.34% | 94 |
|
|
2016
Q2 | $615K | Sell |
9,941
-223
| -2% | -$13.6K | 0.35% | 92 |
|
|
2016
Q1 | $581K | Buy |
10,164
+309
| +3% | +$17.2K | 0.35% | 93 |
|
|
2015
Q4 | $584K | Buy |
9,855
+252
| +3% | +$14.5K | 0.37% | 88 |
|
|
2015
Q3 | $522K | Buy |
9,603
+86
| +0.9% | +$5.6K | 0.36% | 90 |
|
|
2015
Q2 | $639K | Sell |
9,517
-960
| -9% | -$62.7K | 0.41% | 84 |
|
|
2015
Q1 | $613K | Buy |
+10,477
| New | +$633K | 0.38% | 88 |
|
Other funds holding ABBV
VCM
VPM
River Wealth Advisors's ABBV Position: Q1 2026 in Review
River Wealth Advisors reduced its AbbVie (ABBV) stake by 7.8% in Q1 2026, selling an estimated $256K and leaving 13,717 shares worth $2.98M. The position accounts for 0.34% of the portfolio, ranked #67.
River Wealth Advisors first reported a position in ABBV in Q1 2015 and has held it in 45 quarters since. The position peaked at $3.77M in Q2 2022. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- River Wealth Advisors held 13,717 shares of AbbVie worth $2.98M as of Q1 2026.
- River Wealth Advisors sold 1,155 AbbVie shares in Q1 2026, an estimated $256K.
- AbbVie made up 0.34% of River Wealth Advisors's portfolio in Q1 2026, its #67 holding.
- River Wealth Advisors first reported a position in AbbVie in Q1 2015 and has held it in 45 quarters since.
- River Wealth Advisors's AbbVie position peaked at $3.77M in Q2 2022.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on River Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.